No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Express News | NYSE Order Imbalance 104610.0 Shares on Buy Side
Express News | NYSE Order Imbalance 56041.0 Shares on Buy Side
Express News | NYSE Order Imbalance 107268.0 Shares on Buy Side
Express News | European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (Denosumab) Biosimilar Candidate Hlx14
Express News | NYSE Order Imbalance 91009.0 Shares on Sell Side
Organon & Co Spearheads Kahn Brothers' Strategic Portfolio Enhancements in Q1 2024